Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1991-09-16
1992-11-24
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514530, 514570, 514913, A61K 3119, A61K 31215
Patent
active
051661780
ABSTRACT:
The present invention relates to ocular hypotensive agents which contains 13,14-dihydro-15-keto-prostagrandins, which shows no transient ocular hypertensive response that PGs usually show.
REFERENCES:
Exp. Eye. Research 44, 825-837 (1987).
Graefe's Arch. Clin. Exp. Ophthalmol. (1985) 222:139-141.
Investigative Ophthalmology and Visual Science by Bito, May 1982, vol. 22, No. 5.
Acta. Physiol. and Scand. 1966, 66.509-510.
Journal of Chromatography, vol. 156, 1978, pp. 131-141.
Arch. Int. Pharmacodyn., vol. 207, 1974, pp. 131-138.
Invest. Ophthalmol. Visual Sci., vol. 16, No. 12, Dec. 1977, pp. 1125-1134.
Acta Physiol. Scand., vol. 66, 1966, pp. 509-510.
Ueno Ryuji
Ueno Ryuzo
Fay Zohreh A.
K.K. Ueno Seiyaku Oyo Kenkyujo
Waddell Frederick E.
LandOfFree
Ocular hypotensive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ocular hypotensive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular hypotensive agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921920